Autism Analytica announced it has collaborated with Magellan Health Inc., to clinically evaluate a set of subjective and objective measurement tools focused on facilitating the early identification of autism spectrum disorder (ASD) and the monitoring of behavior therapy intervention. Autism Analytica software is designed for use by clinicians evaluating children with ASD and related developmental conditions, as well as behavioral health specialists providing intervention services to children with ASD. Through this collaboration, Magellan will pilot the software to one of its applied behavioral analysis (ABA) network providers.

Autism Analytica and Magellan aim to deliver superior clinical tools and resources which will positively impact the clinical outcomes of members. Magellan will be positioned to enhance services to the automated community by identifying the accurate level of treatment based on both subjective and objective outcomes driven data. Autism Analytica's commercial software has modules that are specifically designed to provide key information to clinicians, including objective measurements, to improve the early identification of children on the autism spectrum.

Additional modules not only predict the type and frequency of services needed but also monitor a child's progress through treatment over time via automated workflows and clinically-validated measures that are completed by a parent or caregiver. Two products are offered by Autism Analytica, Virtual IPM and Neuro IPM. As clinical decision support software, Virtual IPM measures a child's cognitive and behavioral strengths and challenges, collects developmental and medical history information to increase the efficiency of clinical workflows, and provides clinicians with interpretations, recommendations, and treatment targets to permit a rapid transition from evaluation to intervention.

Neuro IPM couples webcam-collected gaze and facial expression technology with proprietary stimuli and AI/machine-learning algorithms to provide objective measurement capabilities that supplement parent-report and other clinical information.